| Literature DB >> 31130363 |
Linda Clijsters1, Claire Hoencamp1, Jorg J A Calis2, Antonio Marzio1, Shanna M Handgraaf1, Maria C Cuitino3, Brad R Rosenberg4, Gustavo Leone3, Michele Pagano5.
Abstract
E2F1, E2F2, and E2F3A, the three activators of the E2F family of transcription factors, are key regulators of the G1/S transition, promoting transcription of hundreds of genes critical for cell-cycle progression. We found that during late S and in G2, the degradation of all three activator E2Fs is controlled by cyclin F, the substrate receptor of 1 of 69 human SCF ubiquitin ligase complexes. E2F1, E2F2, and E2F3A interact with the cyclin box of cyclin F via their conserved N-terminal cyclin binding motifs. In the short term, E2F mutants unable to bind cyclin F remain stable throughout the cell cycle, induce unscheduled transcription in G2 and mitosis, and promote faster entry into the next S phase. However, in the long term, they impair cell fitness. We propose that by restricting E2F activity to the S phase, cyclin F controls one of the main and most critical transcriptional engines of the cell cycle.Entities:
Keywords: E2F1; E2F2; E2F3A; F-box proteins; RNA-seq; SCF ligases; cell cycle; cyclin F; retinoblastoma; ubiquitin
Mesh:
Substances:
Year: 2019 PMID: 31130363 PMCID: PMC6588466 DOI: 10.1016/j.molcel.2019.04.010
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970